Ruxolitinib Impurity 60 | CAS 2102675-36-3 - Request Quote
Ruxolitinib Impurity 60
| SZ CAT No: | SZ-R044092 |
| CAS No | 2102675-36-3 |
| Mol.F. | C8H14N2O |
| Mol.Wt. | 154.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 60 is chemically (R)-5-Cyclopentylpyrazolidin-3-one. Ruxolitinib Impurity 60 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 60 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2102675-36-3
Purchase 2102675-36-3
Order 2102675-36-3
Enquire 2102675-36-3
price of 2102675-36-3
2102675-36-3 Supplier
2102675-36-3 Manufacturer
2102675-36-3 Exporter
buy high quality Ruxolitinib Impurity 60
Purchase Ruxolitinib Impurity 60
Ruxolitinib Impurity 60 suppliers
Ruxolitinib Impurity 60 manufacturers
Ruxolitinib Impurity 60 price
Order Ruxolitinib Impurity 60
Enquire Ruxolitinib Impurity 60
Ruxolitinib Impurity 60 cost
Ruxolitinib Impurity 60 Supplier
Ruxolitinib Impurity 60 Distributor
Ruxolitinib Impurity 60 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 60 for ANDA Filing
Ruxolitinib Impurity 60 for Forced Degradation Studies
Ruxolitinib Impurity 60 Identification Standards
Ruxolitinib Impurity 60 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.